These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38389223)

  • 1. Global health inequalities of chronic kidney disease: a meta-analysis.
    Duff R; Awofala O; Arshad MT; Lambourg E; Gallacher P; Dhaun N; Bell S
    Nephrol Dial Transplant; 2024 Sep; 39(10):1692-1709. PubMed ID: 38389223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.
    Hill NR; Fatoba ST; Oke JL; Hirst JA; O'Callaghan CA; Lasserson DS; Hobbs FD
    PLoS One; 2016; 11(7):e0158765. PubMed ID: 27383068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of chronic kidney disease stages 3-5 in low- and middle-income countries in Asia: A systematic review and meta-analysis.
    Suriyong P; Ruengorn C; Shayakul C; Anantachoti P; Kanjanarat P
    PLoS One; 2022; 17(2):e0264393. PubMed ID: 35213610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010.
    Mills KT; Xu Y; Zhang W; Bundy JD; Chen CS; Kelly TN; Chen J; He J
    Kidney Int; 2015 Nov; 88(5):950-7. PubMed ID: 26221752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD Chronic Kidney Disease Collaboration
    Lancet; 2020 Feb; 395(10225):709-733. PubMed ID: 32061315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of unrecognized or "silent" myocardial ischemia in chronic kidney disease patients: Protocol for a systematic review and meta-analysis.
    Fokoua-Maxime CD; Seukep AJ; Bellouche Y; Cheuffa-Karel TE; Nsagha DS; Kaze FF
    PLoS One; 2021; 16(9):e0256934. PubMed ID: 34473787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis.
    Musso G; Gambino R; Tabibian JH; Ekstedt M; Kechagias S; Hamaguchi M; Hultcrantz R; Hagström H; Yoon SK; Charatcharoenwitthaya P; George J; Barrera F; Hafliðadóttir S; Björnsson ES; Armstrong MJ; Hopkins LJ; Gao X; Francque S; Verrijken A; Yilmaz Y; Lindor KD; Charlton M; Haring R; Lerch MM; Rettig R; Völzke H; Ryu S; Li G; Wong LL; Machado M; Cortez-Pinto H; Yasui K; Cassader M
    PLoS Med; 2014 Jul; 11(7):e1001680. PubMed ID: 25050550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators
    Lancet; 2018 Nov; 392(10159):1789-1858. PubMed ID: 30496104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disparities in Chronic Kidney Disease Prevalence among Males and Females in 195 Countries: Analysis of the Global Burden of Disease 2016 Study.
    Bikbov B; Perico N; Remuzzi G;
    Nephron; 2018; 139(4):313-318. PubMed ID: 29791905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Food supplementation for improving the physical and psychosocial health of socio-economically disadvantaged children aged three months to five years.
    Kristjansson E; Francis DK; Liberato S; Benkhalti Jandu M; Welch V; Batal M; Greenhalgh T; Rader T; Noonan E; Shea B; Janzen L; Wells GA; Petticrew M
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009924. PubMed ID: 25739460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-sectional study of association between socioeconomic indicators and chronic kidney disease in rural-urban Ghana: the RODAM study.
    Adjei DN; Stronks K; Adu D; Beune E; Meeks K; Smeeth L; Addo J; Owusu-Dabo E; Klipstein-Grobusch K; Mockenhaupt FP; Danquah I; Spranger J; Bahendeka S; De-Graft Aikins A; Agyemang C
    BMJ Open; 2019 May; 9(5):e022610. PubMed ID: 31129570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of sarcopenia in patients with chronic kidney disease: a global systematic review and meta-analysis.
    Duarte MP; Almeida LS; Neri SGR; Oliveira JS; Wilkinson TJ; Ribeiro HS; Lima RM
    J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):501-512. PubMed ID: 38263952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of low bone mineral density (T-score ≤  - 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis.
    Duarte MP; Ribeiro HS; Neri SGR; Almeida LS; Oliveira JS; Viana JL; Lima RM
    Osteoporos Int; 2023 Mar; 34(3):467-477. PubMed ID: 36370217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis.
    Kaze AD; Ilori T; Jaar BG; Echouffo-Tcheugui JB
    BMC Nephrol; 2018 Jun; 19(1):125. PubMed ID: 29859046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary Approaches to Stop Hypertension and risk of chronic kidney disease: A systematic review and meta-analysis of observational studies.
    Mozaffari H; Ajabshir S; Alizadeh S
    Clin Nutr; 2020 Jul; 39(7):2035-2044. PubMed ID: 31669002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019.
    Deng Y; Li N; Wu Y; Wang M; Yang S; Zheng Y; Deng X; Xiang D; Zhu Y; Xu P; Zhai Z; Zhang D; Dai Z; Gao J
    Front Endocrinol (Lausanne); 2021; 12():672350. PubMed ID: 34276558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of polypharmacy and associated adverse health outcomes in adult patients with chronic kidney disease: protocol for a systematic review and meta-analysis.
    Okpechi IG; Tinwala MM; Muneer S; Zaidi D; Ye F; Hamonic LN; Khan M; Sultana N; Brimble S; Grill A; Klarenbach S; Lindeman C; Molnar A; Nitsch D; Ronksley P; Shojai S; Soos B; Tangri N; Thompson S; Tuot D; Drummond N; Mangin D; Bello AK
    Syst Rev; 2021 Jul; 10(1):198. PubMed ID: 34218816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs associated with chronic kidney disease in the general population and high-risk subgroups: protocol for a systematic review and meta-analysis.
    Motshwari DD; Matshazi DM; Erasmus R; Kengne AP; Matsha TE; George C
    BMJ Open; 2022 Feb; 12(2):e057500. PubMed ID: 35173010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and related risk factors of chronic kidney disease among adults in Luxembourg: evidence from the observation of cardiovascular risk factors (ORISCAV-LUX) study.
    Alkerwi A; Sauvageot N; El Bahi I; Delagardelle C; Beissel J; Noppe S; Roderick PJ; Mindell JS; Stranges S
    BMC Nephrol; 2017 Dec; 18(1):358. PubMed ID: 29221436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.